RIV.V - Canopy Rivers Inc.

TSXV - TSXV Delayed Price. Currency in CAD
3.3100
-0.0700 (-2.07%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close3.3800
Open3.4200
Bid3.2900 x 0
Ask3.3100 x 0
Day's Range3.2600 - 3.4600
52 Week Range0.1550 - 6.3300
Volume354,814
Avg. Volume405,000
Market Cap631.876M
Beta (3Y Monthly)N/A
PE Ratio (TTM)21.22
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • CNW Group6 days ago

    Canopy Rivers to Report Fourth Quarter and Fiscal Year 2019 Financial Results

    TORONTO , June 19, 2019 /CNW/ - Canopy Rivers Inc. (the "Company") (RIV.V) (CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2019 before markets open on Tuesday, July 16, 2019 . The Company's audited consolidated financial statements and Management's Discussion and Analysis for the three and twelve months ended March 31, 2019 will be available on the Company's profile on SEDAR at www.sedar.com and in the Investors section of the Company's website at www.canopyrivers.com. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC), which are currently scheduled to be released on June 20, 2019 .

  • PR Newswire6 days ago

    Canopy Rivers Makes US$10 Million Investment in Plant Genetics Innovator ZeaKal

    TORONTO and SAN DIEGO, June 19, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers", the "Company") (RIV.V) (CNPOF) and ZeaKal, Inc. ("ZeaKal") are pleased to announce an investment and strategic collaboration between Canopy Rivers and ZeaKal, a California-based plant science innovator with proprietary technologies that sustainably increase photosynthesis, improve plant yield and enhance nutritional profiles for a variety of agricultural crops. The investment from Canopy Rivers marks another significant corporate milestone this calendar year for ZeaKal, following the February announcement of its R&D collaboration (link) with Corteva Agriscience (NYSE:CTVA), the recently spun-out and NYSE-listed agricultural science division of DowDuPont.

  • CNW Group12 days ago

    Canopy Rivers announces grant of options

    Canopy Rivers announces grant of options

  • Canopy Rivers Hosts Analyst and Investor Day on May 28 - Live Webcast Available
    CNW Group28 days ago

    Canopy Rivers Hosts Analyst and Investor Day on May 28 - Live Webcast Available

    TORONTO , May 28, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V), (CNPOF) will be hosting its analyst and investor day from 1:00 p.m. to 5:00 p.m. ET today, May 28 . The webcast will be available on Canopy Rivers' website immediately prior to the event at www.canopyrivers.com/investors/events. Bruce Linton , Chairman of the Board, will share his perspective on Canopy Rivers' unique value proposition.  This will be followed by a presentation from senior executives addressing Canopy Rivers' priorities in support of its mission to accelerate success in the global cannabis economy.

  • PR Newswire28 days ago

    Canopy Growth subsidiary and Canopy Rivers portfolio company Vert Mirabel now fully licensed by Health Canada

    MIRABEL, QC, May 28, 2019 /PRNewswire/ - Les Serres Vert Cannabis Inc. ("Vert Mirabel"), a subsidiary of Canopy Growth Corporation (WEED.TO) (CGC) ("Canopy Growth") and a portfolio company of Canopy Rivers Inc. (RIV.V) (CNPOF) ("Canopy Rivers") has received its final cultivation licence from Health Canada. All 700,000 sq. ft. of operating space at Vert Mirabel is now licensed for cannabis production. Vert Mirabel was established in December 2017 between Canopy Growth, Canopy Rivers, and Les Serres Stéphane Bertrand ("Bertrand"). "We are thrilled that the operational infrastructure at Vert Mirabel is now fully online with over 500,000 sq. ft. already in production," said Olivier Dufourmantelle, Chief Operating Officer, Canopy Rivers.

  • PR Newswirelast month

    Canopy Rivers Hosts analyst and Investor Day

    TORONTO, May 23, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) today announced that it will host an analyst and investor day on Tuesday, May 28 from 1:00 p.m. to 5:00 p.m. ET. Bruce Linton, Chairman of the Board, will share his perspective on Canopy Rivers' unique value proposition. This will be followed by a presentation from senior executives addressing Canopy Rivers' priorities in support of its mission to accelerate success in the global cannabis economy.

  • PR Newswirelast month

    Canopy Rivers Appoints Narbé Alexandrian as Chief Executive Officer

    TORONTO, May 22, 2019 /PRNewswire/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (RIV.V) today announced the promotion of former OMERS venture capitalist and Canopy Rivers President, Mr. Narbé Alexandrian, to Chief Executive Officer of the Company, effective immediately. Bruce Linton has transitioned from his role as acting CEO and will continue to provide oversight, deal flow, strategic insight, and opportunities for collaboration and further strategic alignment with Canopy Growth in conjunction with his ongoing role as Chairman of the Canopy Rivers Board of Directors.

  • Canopy Rivers Portfolio Company Agripharm Awarded Outdoor Cultivation Licence
    CNW Grouplast month

    Canopy Rivers Portfolio Company Agripharm Awarded Outdoor Cultivation Licence

    TORONTO , May 21, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to share that its portfolio company, Agripharm Corp. ("Agripharm"), has received its outdoor cultivation license from Health Canada. "We are pleased to see Agripharm diversify its operations and increase its growing capacity with the grant of this outdoor cultivation licence," said Oliver Dufourmantelle, Chief Operating Officer of Canopy Rivers. Founded in 2013, Agripharm is home to both the first cannabis production facility built from the ground up and the first supercritical CO2 extraction lab in Canada .

  • Canopy Rivers Backs BioLumic - Shines Light on New AgTech for the Medical Cannabis Industry
    CNW Grouplast month

    Canopy Rivers Backs BioLumic - Shines Light on New AgTech for the Medical Cannabis Industry

    TORONTO and PALMERSTON NORTH, New Zealand , May 15, 2019 /CNW/ - BioLumic Ltd. ("BioLumic"), creators of a sustainable ultraviolet (UV) crop yield enhancement system, and Canopy Rivers Inc. ("Canopy Rivers") (RIV.V), (CNPOF) today announced a strategic investment from Canopy Rivers. BioLumic extended the Finistere Ventures-led Series A financing round to include Canopy Rivers' strategic investment of US$1.5 million , closing the oversubscribed round at US$6.7 million . This marks Canopy Rivers' first investment in agri-technologies, specifically focused on the promising fields of plant physiology and UV photobiology.

  • Canopy Growth announces offtake agreement with PharmHouse
    PR Newswire2 months ago

    Canopy Growth announces offtake agreement with PharmHouse

    SMITHS FALLS, ON, May 9, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO) (CGC) is pleased to announce today that has signed an offtake agreement with PharmHouse Inc. ("PharmHouse"), a 49 per cent-owned joint venture of Canopy Rivers Inc. (RIV.V) (OTC:CNOPOF). Under the terms of the agreement, PharmHouse has agreed to allocate high quality cannabis flower from an additional 20 per cent of the flowering space available at its Leamington greenhouse facility over the next three years. Boasting 1.3 million square feet of greenhouse grow space, and leveraging the resources of Canopy Growth, Canopy Rivers and its joint venture partner have worked diligently since October 2018 to prepare the facility for licensing.  PharmHouse will leverage Canopy Growth's genetics – selected and supplied by the Company – and flower will be returned to the Company to be sold under Canopy Growth's diverse brands and banners.  Under the terms of the new offtake agreement, PharmHouse is committed to producing GMP-certified, high quality cannabis flower within 18 months of its cultivation license and the flower must comply with the Company's high standards for cannabis quality.

  • Canopy Rivers Announces Significant Supply Agreement Between PharmHouse and Canopy Growth
    CNW Group2 months ago

    Canopy Rivers Announces Significant Supply Agreement Between PharmHouse and Canopy Growth

    TORONTO , May 9, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to announce that its portfolio company PharmHouse Inc. ("PharmHouse") has entered into a second offtake agreement (the "Agreement") with Canopy Growth Corporation ("Canopy Growth") (WEED.TO) (CGC) for the purchase of cannabis from its 1.3 million square foot greenhouse facility upon licensing. The Agreement commits an additional 20% of PharmHouse's flowering space to Canopy Growth for the next three years, in addition to the 10% that was originally committed in May 2018 .

  • PR Newswire2 months ago

    Canopy Rivers congratulates TerrAscend on receiving its EU GMP certification and new distribution agreement

    TORONTO, May 3, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) congratulates its portfolio company TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF) on its announcement yesterday that its facility in Mississauga, Ontario, Canada has been issued a Good Manufacturing Practice ("GMP") certificate in accordance with the rules governing medicinal products in the European Union ("EU"). Only medical cannabis from EU GMP certified facilities, or the equivalent, may be sold in the EU. The regulatory approach has been led by several of the larger EU countries and as such, pharmaceutical grade controls in production were an established requirement from the onset of medical cannabis legalization.

  • ACCESSWIRE2 months ago

    The Top Cannabis Beauty Products Just Hitting the Retail Market

    HOUSTON, TX / ACCESSWIRE / April 30, 2019 / The cannabis beauty market is just beginning to gain momentum. "There is a great deal of room for innovation in his sector, and topicals and beauty products are expected to explode with legalization and the entry of major consumer packaged goods companies," notes market research firm, The Brightfield Group. Some of the top companies benefiting from the news are The Yield Growth Corporation (CSE:BOSS)(OTCQB:BOSQF), Canopy Rivers Inc. (TSXV:RIV)(OTC:CNPOF), and Ovation Science Inc. (CSE:OVAT)(OTC:OVATF).